New Alzheimer’s Drug Delivers Disappointing Outcomes – Client Well being Information
FRIDAY, June 17, 2022 (HealthDay Information) -- An experimental Alzheimer's drug referred to as crenezumab didn't forestall or gradual psychological decline in sufferers with a...